Oracle E-Business Suite is widely used enterprise ERP; this vulnerability permits takeover of Product Hub and may affect other EBS products, warranting broad IT notification.
CVE-2026-61312
Remote takeover of Oracle E-Business Suite Product Hub (12.2.3–12.2.15).
Is CVE-2026-61312 being exploited?
Not confirmed. CVE-2026-61312 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.33% probability of exploitation in the next 30 days.
How severe is CVE-2026-61312?
CVE-2026-61312 is rated High with a CVSS score of 8.5. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-61312?
Yes. A fix has been recorded for CVE-2026-61312. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-61312 affect?
CVE-2026-61312 affects Oracle E-Business Suite Product Hub 12.2.3–12.2.15, Oracle E-Business Suite (potential scope change to other modules). Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-61312?
Isolate Product Hub, restrict HTTP access, apply vendor patch/mitigations ASAP.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Low-privileged network attacker can compromise Oracle Product Hub, leading to full confidentiality, integrity, availability loss and potential lateral impact to other EBS components.
Immediate action required
- affected>= 12.2.3 and <= 12.2.15
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.